Galectin-3/MAC-2 in experimental allergic encephalomyelitis

Experimental Neurology

Volumn 160, Issue 2, 1999, Pages 508-514

  Reichert, Fanny ^a   Rotshenker, Shlomo ^a  

^a HEBREW UNIVERSITY   (Israel)

Author keywords

CR3; EAE; Galectin 3 MAC 2; Glatiramer acetate copolymer 1; MAC 1; Macrophage microglia; Multiple sclerosis

Indexed keywords

FREUND ADJUVANT; GALAPTIN; GALECTIN 3; GLATIRAMER; MYELIN; PERTUSSIS TOXIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CELL ACTIVATION; CELL DIFFERENTIATION; CONTROLLED STUDY; DEMYELINATION; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; MACROPHAGE; MALE; MICROGLIA; MONOCYTE; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL;

EID: 0032763663     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1999.7229     Document Type: Article

References (32)

1. Aharoni R., Teitelbaum D., Sela M., Arnon R. Copolymer 1 induces T cells of the T helper type 2 that crossreact with myelin basic protein and suppress experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA. 94:1997;10821-10826.
2. Arnon R., Sela M., Teitelbaum D. New insights into the mechanism of action of copolymer 1 in experimental allergic encephalomyelitis and multiple sclerosis. J. Neurol. 243:1996;S8-S13.
3. Austyn J. M., Gordon S. F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur. J. Immunol. 11:1981;805-815.
4. Badovinac V., Mostarica-Stojkovic M., Dinarello C. A., Stosic-Grujicic S. Interleukin-1 receptor antagonist suppresses experimental autoimmune encephalomyelitis (EAE) in rats by influencing the activation and proliferation of encephalitogenic cells. J. Neuroimmunol. 85:1998;87-95.
5. Be'eri H., Reichert F., Saada A., Rotshenker S. The cytokine network of wallerian degeneration: IL-10 and GM-CSF. Eur. J. Neurosci. 10:1998;2707-2713.
6. Bernard C. C., Carnegie P. R. Experimental autoimmune encephalomyelitis in mice: Immunologic response to mouse spinal cord and myelin basic proteins. J. Immunol. 114:1975;1537-1540.
7. Brown E. J. Complement receptors and phagocytosis. Curr. Opin. Immunol. 3:1991;76-82.
8. Bruck W., Friede R. L. The role of complement in myelin phagocytosis during PNS wallerian degeneration. J. Neurol. Sci. 103:1991;182-187.
9. Dejong B. A., Smith M. E. A role for complement in phagocytosis of myelin. Neurochem. Res. 22:1997;491-498.
10. Elliott M. J., Strasser A., Metcalf D. Selective up-regulation of macrophage function in granulocyte-macrophage colony-stimulating factor transgenic mice. J. Immunol. 147:1991;2957-2963.
11. Hughes P. E., Pfaff M. Integrin affinity modulation. Trends. Cell Biol. 8:1998;359-364.
12. Jacobs C. A., Baker P. E., Roux E. R., Picha K. S., Toivola B., Waugh S., Kennedy M. K. Experimental autoimmune encephalomyelitis is exacerbated by IL-1 alpha and suppressed by soluble IL-1 receptor. J. Immunol. 146:1991;2983-2989.
13. Jeng K. C., Frigeri L. G., Liu F. T. An endogenous lectin, galectin-3 (epsilon BP/Mac-2), potentiates IL-1 production by human monocytes. Immunol. Lett. 42:1994;113-116.
14. Martin D., Near S. L. Protective effect of the interleukin-1 receptor antagonist (IL-1ra) on experimental allergic encephalomyelitis in rats. J. Neuroimmunol. 61:1995;241-245.
15. Mosley K., Cuzner M. L. Receptor-mediated phagocytosis of myelin by macrophages and microglia: Effect of opsonization and receptor blocking agents. Neurochem. Res. 21:1996;481-487.
16. Nibbering P. H., Leijh P. C., Van Furth R. Quantitative immunocytochemical characterization of mononuclear phagocytes. I. Monoblasts, promonocytes, monocytes, and peritoneal and alveolar macrophages. Cell Immunol. 105:1987;374-385.
17. Nibbering P. H., Leijh P. C., Van Furth R. Quantitative immunocytochemical characterization of mononuclear phagocytes. II. Monocytes and tissue macrophages. Immunology. 62:1987;171-176.
18. Pesheva P., Urschel S., Frei K., Probstmeier R. Murine microglial cells express functionally active galectin-3 in vitro. J. Neurosci. Res. 51:1998;49-57.
19. Porter J. C., Hogg N. Integrins take partners: Cross-talk between integrins and other membrane receptors. Trends. Cell Biol. 8:1998;390-396.
20. Raine C. S. Multiple sclerosis: Immune system molecule expression in the central nervous system. J. Neuropathol. Exp. Neurol. 53:1994;328-337.
21. Raine C. S. The Dale E. McFarlin Memorial Lecture: The immunology of the multiple sclerosis lesion. Ann. Neurol. 36 Suppl:S61-72:1994;S61-S72.
22. Reichert F., Rotshenker S. Deficient activation of microglia during optic nerve degeneration. J. Neuroimmunol. 70:1996;153-161.
23. Reichert F., Saada A., Rotshenker S. Peripheral nerve injury induces Schwann cells to express two macrophage phenotypes: Phagocytosis and the galactose-specific lectin MAC-2. J. Neurosci. 14:1994;3231-3245.
24. Rinner W. A., Bauer J., Schmidts M., Lassmann H., Hickey W. F. Resident microglia and hematogenous macrophages as phagocytes in adoptively transferred experimental autoimmune encephalomyelitis: An investigation using rat radiation bone marrow chimeras. Glia. 14:1995;257-266.
25. Ross G. D., Vetvicka V. CR3 (CD11b, CD18): A phagocyte and NK cell membrane receptor with multiple ligand specificities and functions. Clin. Exp. Immunol. 92:1993;181-184.
26. Saada A., Reichert F., Rotshenker S. Granulocyte macrophage colony stimulating factor produced in lesioned peripheral nerves induces the up-regulation of cell surface expression of MAC-2 by macrophages and Schwann cells. J. Cell Biol. 133:1996;159-167.
27. Smith M. E. Phagocytosis of myelin in demyelinative disease: A review. Neurochem. Res. 24:1999;261-268.
28. Stoll G., Jander S. The role of microglia and macrophages in the pathophysiology of the CNS. Prog. Neurobiol. 58:1999;233-247.
29. Utz U., McFarland H. F. The role of T cells in multiple sclerosis: Implications for therapies targeting the T cell receptor. J. Neuropathol. Exp. Neurol. 53:1994;351-358.
30. Van Der Laan L. J., Ruuls S. R., Weber K. S., Lodder I. J., Dopp E. A., Dijkstra C. D. Macrophage phagocytosis of myelin in vitro determined by flow cytometry: Phagocytosis is mediated by CR3 and induces production of tumor necrosis factor-alpha and nitric oxide. J. Neuroimmunol. 70:1996;145-152.
31. Wekerle H., Kojima K., Lannes-Vieira J., Lassmann H., Linington C. Animal models. Ann. Neurol. 36:1994;S47-S53.
32. Williams K. C., Ulvestad E., Hickey W. F. Immunology of multiple sclerosis. Clin. Neurosci. 2:1994;229-245.